Revlimid 2.5 mg (Lenalidomide CAPSULE) 2.5 MG

REVLIMID 2.5 MG capsules are a prescription medication used to treat certain blood disorders. This oral treatment is designed to support immune system function and may be used in combination with other therapies.

Strength

2.5 MG

Pack Size

Manufacturer / TM Owner

BRISTOL-MYERS SQUIBB CANADA

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

REVLIMID 2.5 MG capsules are primarily used in the treatment of specific blood disorders, such as myelodysplastic syndromes (MDS) and multiple myeloma. This medication works by helping the immune system to function more effectively, which can support the body's natural defenses. Patients often wonder, 'What is REVLIMID used for?' and the answer lies in its ability to target and manage these complex blood conditions.

Side Effects

Common effects of REVLIMID 2.5 MG capsules may include fatigue, diarrhea, and constipation. Some users also experience muscle cramps or rash. These effects can vary from person to person, and it's important to discuss any concerns with a healthcare provider.

Precautions & Warnings

REVLIMID 2.5 MG capsules should be handled with care, as they are potent medications. It's crucial to follow the prescribed dosage and administration instructions provided by a healthcare professional. Pregnant women should avoid handling this medication due to potential risks.

Avoid Interactions

REVLIMID 2.5 MG capsules may interact with certain medications, including those that affect the immune system or blood clotting. It's important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and other substances that affect the liver should also be discussed with a healthcare professional.

Frequently Asked Questions

REVLIMID is used to treat certain blood disorders, such as myelodysplastic syndromes (MDS) and multiple myeloma.

REVLIMID 2.5 MG capsules are taken orally, typically once daily, as prescribed by a healthcare provider.

Common side effects may include fatigue, diarrhea, constipation, muscle cramps, and rash.

REVLIMID may interact with certain medications, so it's important to discuss all current medications with a healthcare provider.

REVLIMID is not recommended for use during pregnancy due to potential risks. Pregnant women should avoid handling this medication.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.